Onderneming Transcept Pharmaceuticals Inc Nasdaq
Aandelen
US89354M1062
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- USD | - |
|
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Evan Loh
CEO | Chief Executive Officer | 65 | 01-05-12 |
Director of Finance/CFO | - | 01-07-20 | |
Adam Woodrow
PSD | President | 57 | 01-10-14 |
Jonathan Light
CMP | Compliance Officer | - | 01-08-17 |
Raj Padmanabhan
CTO | Chief Tech/Sci/R&D Officer | - | 01-11-15 |
Karen McGrath
HRO | Human Resources Officer | - | 01-07-19 |
Randy Brenner
LAW | General Counsel | 51 | 03-06-15 |
Susan M. Perkins
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Stacey Seltzer
BRD | Director/Board Member | 47 | 21-09-23 |
Evan Loh
CEO | Chief Executive Officer | 65 | 01-05-12 |
Adam Dilluvio
BRD | Director/Board Member | - | 21-09-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 57 322 358 | 46 807 641 ( 81,66 %) | 0 | 81,66 % |
Bedrijfsgegevens
Paratek Pharmaceuticals, Inc.
75 Park Plaza 3rd floor
02116-3934, Boston
+617-807-6600
http://www.paratekpharma.com![Adres Transcept Pharmaceuticals Inc](https://cdn.zonebourse.com/static/address/5050388.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+55,55% | 816 mld. | |
+41,08% | 634 mld. | |
-6,83% | 351 mld. | |
+17,15% | 323 mld. | |
+7,09% | 293 mld. | |
+13,60% | 238 mld. | |
+1,55% | 222 mld. | |
+13,55% | 218 mld. | |
+7,87% | 167 mld. |
- Beurs
- Aandelen
- Koers PRTK
- Koers
- Onderneming Transcept Pharmaceuticals Inc